Skip to main content

Table 1 Clinical characteristics of 37 pediatric cancer patients with mineralizing microangiopathy

From: Mineralizing microangiopathy: radiological features of a "not uncommon" complication of chemoradiotherapy in pediatric cancer patients

No.

Age

Sex

Diagnosis

Clinical symptoms

Signs

Systemic chemotherapy

Radiotherapy

Intrathecal chemotherapy

Years from the end of treatment till MM

1

11

M

ALL

Headache, blurring vision

 

HDMTX-HDAC

Yes

Yes

4

2

1.5

M

ALL

Convulsion

 

HDMTX-HDAC

No

Yes

2

3

8

M

ALL

Convulsion

 

HDMTX –HDAC

Yes

Yes

4

4

4

M

ALL

Convulsion

 

HDMTX

No

Yes

2.5

5

4

F

ALL

Convulsion

Spastic LL

HDMTX

No

Yes

2

 

11

M

ALL

Headache, blurring vision

 

HDMTX-HDAC

Yes

Yes

4

6

16

M

Craniopharyngioma

Headache, Convulsion

 

No

Yes

No

9

7

15

F

Craniopharyngioma

Headache, blurring vision

Squint

No

Yes

No

4

8

3

M

ATRT

Headache

Ataxia

Yes

Yes

Yes

2

9

10

M

Ependymoma

Headache, Convulsion

 

Yes

Yes

No

6

10

11

f

Pineoblastoma

Headache, Convulsion

 

Yes

Yes

No

3

11

11

F

PNET

Headache, Convulsion

 

Yes

Yes

No

8

12

3

M

MB

Headache

Squint

Yes

Yes

No

8

13

10

M

MB

Slurred speech

 

Yes

Yes

No

9

14

11

F

MB

Convulsion, aphasia

 

Yes

Yes

No

5

15

9

F

MB

Convulsion

 

Yes

Yes

No

5

16

5

F

MB

Hearing impairment

 

Yes

Yes

No

1.5

17

3

F

MB

Headache

 

Yes

Yes

No

5

18

3

F

MB

Headache

Spastic LL

Yes

Yes

No

4

19

6

M

MB

Squint

Squint

Yes

Yes

No

3

20

8

M

MB

Convulsion

 

Yes

Yes

No

1

21

9

M

MB

Asymptomatic

 

Yes

Yes

No

7

22

14

M

MB

Headache

 

Yes

Yes

No

2

23

14

M

MB

Asymptomatic

 

Yes

Yes

No

6

24

9

F

MB

Behavioral changes

Ataxia

Yes

Yes

No

10

25

4

F

MB

Ataxia

Ataxia

Yes

Yes

No

4

26

6

F

MB

Headache

 

Yes

Yes

No

2

27

11

M

MB

HEADACH

 

Yes

Yes

No

4

28

15

M

MB

Asymptomatic

 

Yes

Yes

No

7

29

18

M

MB

Asymptomatic

 

Yes

NO

No

10

30

13

F

PNET

Convulsion

 

Yes

Yes

No

6

31

3

F

ATRT

Asymptomatic

 

Yes

Yes

Yes

1

32

8

M

MB

Convulsion

UL paresis

Yes

Yes

No

1

33

1

M

BSG

Convulsion

 

No

Yes

No

1

34

3

M

ATRT

Asymptomatic

 

Yes

Yes

Yes

1

35

1

M

BSG

Convulsion

 

No

Yes

No

1

36

3

M

ATRT

Asymptomatic

 

Yes

Yes

Yes

1

37

6

F

MB

Convulsion, Ataxia

Ataxia

Yes

Yes

No

6

  1. M; Male F; female ALL; acute lymphoblastic leukemia, MB; medulloblastoma, ATRT; atypical tetartoid rhabdoid tumor, PNET; primitive neuroectodermal tumor, BSG; brain stem glioma, HDMTX; high-dose methotrexate, HDAC; high-dose Ara C. UL; upper limb, LL; lower limb